Targeting Lipid Metabolism Enzymes in Breast Cancer: Mechanistic Basis and Therapeutic Vulnerabilities
Authors:
- 9 July 2026
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1030, 179131
Abstract
No abstract availableKeywords
Funding Information
- Tongji University
- Shanghai Municipal Health Commission (202140232)
This publication has 155 references indexed in Scilit:
- Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1/JNK pathwayJournal of Cancer Research and Clinical Oncology, 2024
- Mobility‐Modulated Sequential Dissociation Analysis Enables Structural Lipidomics in Mass Spectrometry ImagingAngewandte Chemie International Edition, 2023
- Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancerCancer Letters, 2021
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapyProtein & Cell, 2020
- Fatty Acid Synthase Inhibitor TVB‐2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic AbnormalitiesHepatology, 2019
- Adiposity and estrogen receptor‐positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiolInternational Journal of Cancer, 2019
- Novel flexible heteroarotinoid, SL-1-39, inhibits HER2-positive breast cancer cell proliferation by promoting lysosomal degradation of HER2Cancer Letters, 2019
- Breast Cancer TreatmentJAMA, 2019
- Lipid storage and lipophagy regulates ferroptosisBiochemical and Biophysical Research Communications, 2019
- Lipid Regulation of the ABCB1 and ABCG2 Multidrug Transporters2015